Company Filing History:
1 out of 4 
1 out of 15 Years Active: 2012
Title: Sophie Le Ricousse-Roussanne: Innovator in Cell/Ligand Marking Systems
Introduction
Sophie Le Ricousse-Roussanne is a notable inventor based in Champigny sur Marne, France. She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative marking systems for cells and ligands. Her work focuses on enhancing therapeutic applications, especially in the context of vascular insufficiencies.
Latest Patents
Sophie holds a patent for a "Cell/ligand marking system, wherein the marker is of Eph type, cell material comprising said system, method for preparing same and proangiogenetic use." This invention features a specific marking system characterized by an endothelial precursor cell (EPC) that includes a cell marker from the Eph group, particularly EphB4 or EphB1. The system also incorporates a protein material that consists of a ligand specific to the marker, associated with a binding protein. This innovative approach aims to provide a proangiogenetic cell material capable of stimulating angiogenesis, with potential therapeutic applications for vascular insufficiencies.
Career Highlights
Throughout her career, Sophie has worked with esteemed organizations such as the Institut des Vaisseaux et du Sang and Université Paris 7—Denis Diderot. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Sophie has collaborated with notable colleagues, including Philippe Foubert and Jean-Sebastien Silvestre. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.
Conclusion
Sophie Le Ricousse-Roussanne is a pioneering inventor whose work in cell/ligand marking systems has the potential to transform therapeutic approaches to vascular insufficiencies. Her contributions to the field highlight the importance of innovation in biomedical research.